Especially subchondral bone activity and synovitis open new possibilities for treatment. Promising treatments to modify the disease are currently investigated.Disclosure of InterestNone declareddoi:10.1136/annrheumdis-2015-eular.6757KloppenburgM.Annals of the Rheumatic Diseases...
Background There is growing evidence for tapering biologic therapies in patients with rheumatoid arthritis in sustained clinical remission to avoid overtreatment and minimise side-effects. Ultrasound assessment for subclinical synovitis ... H Pillai,N Nolkha,A Yau,... - 《Rheumatology》 被引量: 0发...
For injections of corticosteroid to treat inflammation Symptoms of nonseptic bursitis are often effectively treated with rest and 10 to 14 days of nonsteroidal anti-inflammatory drugs. However, when needed, bursal injection therapy provides rapid relief, whic...
It's common for dogs to scoot or drag their bottoms across the ground after doing their business -- especially if their stool is loose. But if a dog scoots a lot all day, see your vet. Scooting can mean impacted anal glands, which you should get your vet to treat. It could also ...
Intravenous immunoglobulin (IVIG) therapy is used to treat immunodeficient patients, but it can also suppress various autoimmune and chronic inflammatory diseases. Despite the clinical success of IVIG therapy, its mechanisms of action remain controversia
For more information, please refer to https://www.mdpi.com/openaccess. Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an ...
Although both bone marrow and synovial fluid represent an attractive tissue source for MSCs and have the potential to treat cases with articular cartilage injuries, results from our laboratory have shown that the properties of MSCs are donor-dependent, which could potentially affect their clinical effi...
Synthetic DMARDs are not effective in treating axial inflammation in SpA but can be effective for the therapy of peripheral synovitis with sulfasalazine being the preferred drug. The ultimate treatment target in axial SpA is clinical remission, and the abrogation of inflammation seems to play an ...
In patients presenting with intraarticular swelling, the differential diagnosis also includes pigmented villonodular synovitis (PVNS), a disorder which is uncommon and therefore less well known, and may be difficult to treat.doi:10.3109/17453679809117632...
derivative or a pharmaceutically acceptable salt thereof (OA), rheumatoid arthritis, synovitis, subchondral bone edema, and cartilage degradation ( OA and related and to treat the symptoms or disease selected from the group consisting of disorder ), prevent, or to a method for lessening the ...